Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling
Sponsor: Erasmus Medical Center
Summary
The goal of this observational study is to investigate whether circulating tumor-derived DNA (ctDNA) can be reliably detected and analyzed in blood obtained through automated capillary sampling in adult patients (≥21 years) with colorectal liver metastases (CRLM). The main question it aims to answer is: * Can ctDNA be detected in small volumes of capillary blood collected using an automated sampling device? * Do ctDNA levels measured in capillary blood agree with those measured in venous blood from the same patients? Researchers will compare ctDNA measurements from capillary blood to those from venous blood (reference standard) to see if capillary sampling provides reliable results for ctDNA analysis. Participants will: * Provide a small blood sample through automated capillary collection. * Provide a venous blood sample during the same study visit for comparison.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
OBSERVATIONAL
Enrollment
35
Start Date
2025-11-17
Completion Date
2027-11
Last Updated
2026-01-06
Healthy Volunteers
Not specified
Conditions
Interventions
Blood Collection - TAP® Device
K2EDTA BD Microtainer
Blood Collection - Venous
10 mL EDTA Collection Tube
Locations (1)
Erasmus MC University Medical Center
Rotterdam, South Holland, Netherlands